ChampionX Corporation [NYSE: CHX] traded at a high on 10/23/20, posting a 0.59 gain after which it closed the day’ session at $8.51. The company report on October 14, 2020 that ChampionX Announces Third Quarter 2020 Earnings Release and Conference Call Schedule.
ChampionX Corporation (“ChampionX”) (NYSE: CHX) announced today that it will release its third quarter 2020 operating results on Wednesday, October 28, 2020 after the market closes. The Company has scheduled a conference call for Thursday, October 29, 2020 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time) to discuss the results.
Get 12 free stock market lessons delivered to your email from Investor's Business Daily, the leader in investing education for over 35 years. We’ll cover the basics of better investing and show you how to give yourself an edge in the market.
GET FREE LESSON outside the norm.
The call will be available by live webcast on ChampionX’s website at www.investors.championx.com or by dialing in as follows:.
The results of the trading session contributed to over 1273900 shares changing hands. Over the past one week, the price volatility of ChampionX Corporation stands at 5.43% while the volatility over the past one month is 5.89%.
The market cap for CHX stock reached $1.69 billion, with 199.81 million shares outstanding and 198.72 million shares in the current float. Compared to the average trading volume of 1.94M shares, CHX reached a trading volume of 1273900 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ChampionX Corporation [CHX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CHX shares is $14.05 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CHX stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Scotiabank have made an estimate for ChampionX Corporation shares, keeping their opinion on the stock as Sector Outperform, with their previous recommendation back on September 16, 2020. While these analysts kept the previous recommendation, Credit Suisse raised their target price to Outperform. The new note on the price target was released on September 11, 2020, representing the official price target for ChampionX Corporation stock. Previously, the target price had yet another raise to $16, while Evercore ISI analysts kept a Outperform rating on CHX stock.
The Average True Range (ATR) for ChampionX Corporation is set at 0.51, with the Price to Sales ratio for CHX stock in the period of the last 12 months amounting to 1.56. The Price to Book ratio for the last quarter was 0.61, with the Price to Cash per share for the same quarter was set at 0.71. Price to Free Cash Flow for CHX in the course of the last twelve months was 12.23 with Quick ratio for the last quarter at 1.30.
How has CHX stock performed recently?
ChampionX Corporation [CHX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.04. With this latest performance, CHX shares gained by 3.91% in over the last four-week period, additionally sinking by -1.28% over the last 6 months – not to mention a drop of -67.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CHX stock in for the last two-week period is set at 49.03, with the RSI for the last a single of trading hit 54.41, and the three-weeks RSI is set at 47.43 for ChampionX Corporation [CHX]. The present Moving Average for the last 50 days of trading for this stock 9.13, while it was recorded at 8.27 for the last single week of trading, and 12.12 for the last 200 days.
ChampionX Corporation [CHX]: Deeper insight into the fundamentals
ChampionX Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 2.30.
Earnings analysis for ChampionX Corporation [CHX]
With the latest financial reports released by the company, ChampionX Corporation posted 0.27/share EPS, while the average EPS was predicted by analysts to be reported at 0.32/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -15.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CHX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ChampionX Corporation go to -12.64%.
Insider trade positions for ChampionX Corporation [CHX]
There are presently around $1,701 million, in the hands of institutional investors. The top three institutional holders of CHX stocks are: BLACKROCK INC. with ownership of 23,048,767, which is approximately 236.866% of the company’s market cap and around 0.60% of the total institutional ownership; VANGUARD GROUP INC, holding 18,604,265 shares of the stock with an approximate value of $158.32 million in CHX stocks shares; and BOSTON PARTNERS, currently with $85.67 million in CHX stock with ownership of nearly 112.363% of the company’s market capitalization.
206 institutional holders increased their position in ChampionX Corporation [NYSE:CHX] by around 131,530,108 shares. Additionally, 99 investors decreased positions by around 5,174,803 shares, while 39 investors held positions by with 63,120,925 shares. The mentioned changes placed institutional holdings at 199,825,836 shares, according to the latest SEC report filing. CHX stock had 78 new institutional investments in for a total of 41,832,170 shares, while 47 institutional investors sold positions of 2,544,174 shares during the same period.